Swiss National Bank Chinook Therapeutics, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$18.66 - $38.58 $197,796 - $408,948	10,600 Added 11.82%	100,300 $3.85 Million
Q1 2023 May 10, 2023	SELL	$21.53 - $26.8 $193,770 - $241,200	-9,000 Reduced 9.12%	89,700 $2.08 Million
Q4 2022 Feb 08, 2023	BUY	$18.63 - $27.35 $96,876 - $142,220	5,200 Added 5.56%	98,700 $2.59 Million
Q2 2022 Aug 09, 2022	BUY	$12.59 - $18.8 $1.18 Million - $1.76 Million	93,500 New	93,500 $1.64 Million

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.